HCA Healthcare Inc (HCA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HCA Healthcare Inc (HCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9896
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and ancillary health care services; diagnostic and emergency services and mental health care services. The company operates a network of hospitals; freestanding surgery centers and emergency care facilities; diagnostic and imaging centers; radiation and oncology therapy centers; comprehensive rehabilitation and physical therapy centers; and various other facilities. It operates its facilities in the US and in England, the UK. HCA is headquartered in Nashville, Tennessee, the US.

HCA Healthcare Inc (HCA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
HCA Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
HCA Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
HCA Completes Acquisition Of Galichia Heart Hospital 13
Partnerships 14
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14
HCA Enters into Research Agreement with Harvard Pilgrim Health Care 16
National HealthCare Enters Into Joint Venture Agreement With TriStar Health System 17
TriStar Health System Enters Into Joint Venture Agreement With CareSpot 18
Debt Offering 19
HCA Prices Public Offering of 5.375% Notes Due 2025 for USD1.6 Billion 19
HCA Prices Public Offering of 5.25% Notes Due 2025 for USD1.4 Billion 21
HCA Prices Public Offering of 4.25% Notes Due 2019 for USD600 Million 23
HCA Raises USD2 Billion in Public Offering of 5% Notes Due 2024 25
HCA Raises USD1.5 Billion in Public Offering of 3.75% Notes Due 2019 27
HCA Completes Public Offering Of Notes Due 2021 For US$1 Billion 29
HCA Holdings Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 31
HCA Holdings Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 33
HCA Completes Public Offering Of Notes Due 2022 For US$1.35 Billion 35
Acquisition 37
HCA Holdings to Acquire CareNow 37
HCA Holdings Rumored To Bid For Healthscope For US$4.5 Billion 38
Parallon Business Solutions Completes Acquisition Of The Outsource Group From ClearLight Partners 40
TriStar Health System And CareSpot Acquire NeighborMD 42
Citrus Memorial Health System Plans To Sell Itself 43
HCA Healthcare Inc – Key Competitors 45
HCA Healthcare Inc – Key Employees 46
HCA Healthcare Inc – Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Joint Venture 50
Recent Developments 52
Strategy And Business Planning 52
Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 52
Financial Announcements 53
Oct 30, 2018: HCA reports third quarter 2018 results 53
Jul 25, 2018: HCA Reports Second Quarter 2018 Results 55
May 01, 2018: HCA Reports First Quarter 2018 Results 57
Jan 30, 2018: HCA Reports Revenue Of $43.6 Million in 2017 59
Oct 31, 2017: HCA Reports Third Quarter 2017 Results 60
Oct 18, 2017: HCA Previews 2017 Third Quarter Results 62
Jul 25, 2017: HCA Reports Second Quarter 2017 Results 64
May 02, 2017: HCA Reports First Quarter 2017 Results 66
Apr 17, 2017: HCA Previews 2017 First Quarter Results 67
Jan 31, 2017: HCA Reports Fourth Quarter 2016 Results 68
Corporate Communications 70
Sep 10, 2018: HCA Healthcare Chairman and CEO Milton Johnson to Retire; Current President and COO Sam Hazen to Become CEO 70
Jul 19, 2018: Allen Harrison Appointed President of Methodist Healthcare System 71
Jul 02, 2018: Jenn Bowman Named VP of Patient Experience at HCA Healthcare’s Gulf Coast Division 72
Mar 21, 2018: Brian Cook Named President of HCA’s Far West Division 73
Jan 17, 2018: HCA Announces Michael W. Michelson Appointed as New Independent Director 74
Nov 14, 2017: Peyton Elliott Named CEO of Park Plaza Hospital 75
Sep 01, 2017: Ashley Johnson Appointed Chief Financial Officer of HCA Healthcare’s American Group 76
Aug 29, 2017: HCA Healthcare Gives up to $2 Million for Hurricane Relief in Texas 77
Government and Public Interest 78
Sep 06, 2018: Three National Foundations Commit $30 Million to Civica Rx, a Groundbreaking Effort to Address Shortages and High Prices of Life-Saving Medications 78
Appendix 79
Methodology 79
About GlobalData 79
Contact Us 79
Disclaimer 79

List of Tables
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
HCA Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
HCA Healthcare Inc, Deals By Therapy Area, 2012 to YTD 2018 9
HCA Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
HCA Completes Acquisition Of Galichia Heart Hospital 13
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14
HCA Enters into Research Agreement with Harvard Pilgrim Health Care 16
National HealthCare Enters Into Joint Venture Agreement With TriStar Health System 17
TriStar Health System Enters Into Joint Venture Agreement With CareSpot 18
HCA Prices Public Offering of 5.375% Notes Due 2025 for USD1.6 Billion 19
HCA Prices Public Offering of 5.25% Notes Due 2025 for USD1.4 Billion 21
HCA Prices Public Offering of 4.25% Notes Due 2019 for USD600 Million 23
HCA Raises USD2 Billion in Public Offering of 5% Notes Due 2024 25
HCA Raises USD1.5 Billion in Public Offering of 3.75% Notes Due 2019 27
HCA Completes Public Offering Of Notes Due 2021 For US$1 Billion 29
HCA Holdings Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 31
HCA Holdings Completes Public Offering Of Notes Due 2023 For US$1.25 Billion 33
HCA Completes Public Offering Of Notes Due 2022 For US$1.35 Billion 35
HCA Holdings to Acquire CareNow 37
HCA Holdings Rumored To Bid For Healthscope For US$4.5 Billion 38
Parallon Business Solutions Completes Acquisition Of The Outsource Group From ClearLight Partners 40
TriStar Health System And CareSpot Acquire NeighborMD 42
Citrus Memorial Health System Plans To Sell Itself 43
HCA Healthcare Inc, Key Competitors 45
HCA Healthcare Inc, Key Employees 46
HCA Healthcare Inc, Other Locations 48
HCA Healthcare Inc, Subsidiaries 49
HCA Healthcare Inc, Joint Venture 50

List of Figures
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
HCA Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[HCA Healthcare Inc (HCA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DrillingInfo Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary DrillingInfo Inc (DrillingInfo) is an oil and gas service provider that offers upstream drilling services and oilfield services. The company's products include DI courthouse, DI analytics, DI basic, DI engineering, DI international product line, DI geodata services, DI rig analytics, DI play …
  • Orlando Utilities Commission:発電所・企業SWOT分析
    Orlando Utilities Commission - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Oge Energy Corp
    Oge Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Oge Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • McPherson’s Ltd (MCP):企業の財務・戦略的SWOT分析
    McPherson's Ltd (MCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Infineon Technologies AG:企業の戦略・SWOT・財務情報
    Infineon Technologies AG - Strategy, SWOT and Corporate Finance Report Summary Infineon Technologies AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • KVK-Tech Inc-製薬・医療分野:企業M&A・提携分析
    Summary KVK-Tech Inc (KVK-Tech) is a manufacturer and marketer generic drugs. The company's product portfolio includes benzphetamine HCL, betaxolol, chlorphen-12, cyclobenzaprine HCL, diethylpropion HCL, hydroxyzine HCL, indomethacin extended release, phendimetrazine tartrate, phentermine HCL, prome …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Boustead Heavy Industries Corp Bhd:企業の戦略・SWOT・財務情報
    Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Greenbrier Companies, Inc.:企業の戦略・SWOT・財務分析
    The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Interprotein Corp-製薬・医療分野:企業M&A・提携分析
    Summary Interprotein Corp (Interprotein) is a drug discovery company that conducts research and develops small molecule drugs. The company provides IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E and CD94 inhibitor; KIR and HLA-C inhi …
  • Expro Holdings UK 3 Ltd:企業の戦略的SWOT分析
    Expro Holdings UK 3 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Bank of Ayudhya Public Co Ltd (BAY):企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Genesis Energy LP (GEL):企業の財務・戦略的SWOT分析
    Genesis Energy LP (GEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Alliance Resource Partners LP:企業の戦略・SWOT・財務情報
    Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report Summary Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Celanese Corp (CE):企業の財務・戦略的SWOT分析
    Celanese Corp (CE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Synedgen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • Fives:企業の戦略・SWOT・財務分析
    Fives - Strategy, SWOT and Corporate Finance Report Summary Fives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Steel Excel Inc (SXCL):企業の財務・戦略的SWOT分析
    Summary Steel Excel Inc (Steel Excel) is a provider of technology consulting and business development solutions. The company’s services comprise rogue pressure services, sun well services, black hawk energy services, functional fitness facilities, sports training, strength and conditioning gym facil …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆